With institutions

• Université Libre de Bruxelles (Belgium),
• Institut Gustave Roussy, INSERM and APHP (France),
• University of Ohio (USA),
• Université de la Méditerranée (France).

With healthcare companies

• Affymetrix (USA),
• Genzyme Genetics (USA),
• Xenomics (USA),
• LabCorp (USA),
• Warnex (Canada).

In the blood cancer field, Ipsogen is a member of the European LeukemiaNet (ELN) network. The ELN groups together 117 clinical centres in 22 countries.
This network has E.U. grants and studies all diagnostic and therapeutic aspects of leukemias; it allows Ipsogen to strengthen its relationships with cancer research and healthcare institutes.